Physician profile
David J Burkart
NPI 1225078488
$56,397.77
in general payments reported to CMS, 2019-2025
61 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,959 · 2020: $4,798 · 2021: $3,214 · 2022: $5,270 · 2023: $13K · 2024: $15K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Travel and Lodging: $7,885 · Consulting Fee: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,261.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,050.00 |
| Travel and Lodging | $7,885.35 |
| Consulting Fee | $960.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14,790.55 | 2020-2025 | Auryon Laser System 100-120 Vac, Angiovac, Alphavac |
| Shockwave Medical, INC | $14,108.37 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $2,818.43 | 2021-2025 | Indigo System, Penumbra System, Ruby Coil |
| Reflow Medical INC | $2,210.08 | 2024-2025 | |
| Inari Medical, INC. | $1,998.68 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardinal Health 200 LLC | $1,833.56 | 2019-2020 | |
| Philips North America LLC | $1,798.94 | 2019-2025 | Igt Devices Undivided |
| Janssen Pharmaceuticals, INC | $1,656.76 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $1,653.33 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $1,286.78 | 2019-2024 | Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Terumo Medical Corporation | $1,186.66 | 2022-2024 | Glidesheath Slender, Angio-Seal |
| Amgen INC. | $1,181.63 | 2019-2025 | Repatha, Repatha |
| Cordis US Corp. | $1,139.66 | 2023-2024 | Angioguard, Saber, Precise Pro Rx |
| Nevro Corp. | $1,136.41 | 2023-2024 | Senza |
| Silk Road Medical, INC. | $872.33 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $746.79 | 2020-2025 | Watchman Flx, Intracept, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $627.25 | 2019-2024 | Jardiance |
| Abbott Laboratories | $548.88 | 2020-2025 | Cardiomems, Jeti Peripheral Catheter, Diamondback Peripheral |
| Amarin Pharma, INC. | $529.01 | 2019-2022 | |
| Pfizer INC. | $408.40 | 2019-2025 | |
| Medtronic, INC. | $334.30 | 2022-2025 | Pulseselect, Symplicity G3, Resolute Onyx |
| Astrazeneca Pharmaceuticals LP | $266.31 | 2020-2025 | Andexxa |
| Kowa Pharmaceuticals America, INC. | $253.37 | 2019-2022 | |
| Endologix LLC | $248.47 | 2023 | |
| Surmodics, INC. | $245.94 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.50 | 2020-2025 | Lifevest |
| Daiichi Sankyo INC. | $223.73 | 2019-2024 | Injectafer |
| Sanofi-Aventis U.S. LLC | $212.64 | 2019-2024 | |
| Novo Nordisk INC | $194.94 | 2024-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $177.29 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $136.55 | 2021-2022 | |
| United Therapeutics Corporation | $123.11 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $121.28 | 2022-2025 | Amvuttra |
| Ekos Corporation | $116.44 | 2019 | |
| Genzyme Corporation | $97.06 | 2021-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $92.69 | 2024 | Arcalyst |
| Csl Behring | $83.55 | 2020-2021 | |
| Globus Medical, INC. | $72.24 | 2025 | Senza |
| Cleerly, INC. | $67.05 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Arbor Pharmaceuticals, INC. | $52.12 | 2019-2020 | |
| Cardiva Medical, INC. | $46.89 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Esperion Therapeutics, INC. | $43.94 | 2021-2025 | Nexletol |
| Bardy Diagnostics, INC. | $41.49 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $39.27 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $34.01 | 2025 | Assure Wcd |
| Atricure, INC. | $32.51 | 2023 | |
| Azurity Pharmaceuticals, INC. | $31.82 | 2024 | Edarbi |
| Merck Sharp & Dohme LLC | $31.39 | 2021-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $30.20 | 2019 | |
| Abiomed | $29.00 | 2022 | |
| Astellas Pharma US INC | $21.24 | 2019 | |
| Cook Medical LLC | $19.31 | 2024 | Performer |
| Balt USA, LLC | $19.16 | 2023 | Prestige Coil System |
| Biocompatibles, INC. | $17.09 | 2019 | |
| Medline Industries LP | $14.45 | 2022 | |
| Vifor Pharma, INC. | $12.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.40 | 2019 | |
| Irhythm Technologies, INC. | $12.40 | 2019 | |
| Tactile Systems Technology INC | $12.25 | 2021 | |
| Cvrx, INC. | $9.61 | 2022 | |
| Merit Medical Systems INC | $6.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Burkart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.